Viewing Study NCT00695357


Ignite Creation Date: 2025-12-24 @ 7:02 PM
Ignite Modification Date: 2026-01-01 @ 5:45 PM
Study NCT ID: NCT00695357
Status: COMPLETED
Last Update Posted: 2009-04-30
First Post: 2008-06-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006
Sponsor: AstraZeneca
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: NIS-RGR-DUM-2008/1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Pontikis Panagiotis, MD, Medical and Regulatory Director, AstraZeneca Greece
Old Organization: AstraZeneca SA, Greece

Collaborators